Red No. 3 Ban: FDA Revokes FD&C Red No. 3 for Food & Drugs

Overview

On January 15, 2025, the U.S. Food and Drug Administration issued a final order revoking the color additive listings for FD&C Red No. 3 (erythrosine) in food and ingested drugs. Published in the Federal Register at 90 FR 4628 (January 16, 2025), the order revokes 21 CFR 74.303 (food use) and 21 CFR 74.1303 (drug use), with staggered compliance deadlines: January 15, 2027 for food products and January 18, 2028 for ingested drugs.

This is not a discretionary safety judgment. The FDA revoked the listings "as a matter of law" under the Delaney Clause — Section 721(b)(5)(B) of the Federal Food, Drug, and Cosmetic Act — which categorically prohibits the authorization of any color additive found to cause cancer in humans or animals. The agency explicitly acknowledged that the mechanism of carcinogenicity observed in male rats (thyroid hormone disruption) does not occur in humans at typical dietary exposure levels. Under the Delaney Clause, that distinction is legally irrelevant.

The Red No. 3 ban represents the first formal revocation of a permanently listed synthetic food dye in over three decades. It also marks the beginning of a broader federal effort to eliminate all petroleum-based synthetic food colorings from the U.S. food supply.

Current Regulatory Status

Federal Ban

The federal ban is enacted and final. The FDA's order was issued under the Biden administration on January 15, 2025, in response to a color additive petition filed by the Center for Science in the Public Interest (CSPI) and 22 co-petitioners in October 2022 (docket FDA-2023-N-0437). The deadline for objections and hearing requests passed on February 18, 2025, and no formal challenges were sustained.

The Trump administration did not reverse or delay the Red No. 3 ban. To the contrary, on April 22, 2025, HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary announced a broader phase-out of all petroleum-based synthetic food dyes as part of the Make America Healthy Again (MAHA) initiative. The announcement accelerated the timeline: the FDA called on food companies to remove Red No. 3 ahead of the January 2027 statutory deadline and initiated proceedings to revoke two additional dyes (Citrus Red No. 2 and Orange B), while setting voluntary elimination targets for the remaining six certified synthetic dyes by end of 2026.

California — AB 418 (California Food Safety Act)

California's AB 418, signed by Governor Gavin Newsom on October 7, 2023, independently bans the manufacture, sale, or distribution of food containing Red No. 3, potassium bromate, propylparaben, or brominated vegetable oil. The California ban takes effect January 1, 2027 — two weeks before the federal food deadline. Enforcement is handled by the California Attorney General and local prosecutors, with civil penalties of up to $5,000 for a first violation and $10,000 for subsequent violations.

California also enacted AB 2316 (2024), banning six synthetic dyes from school food service by December 31, 2027. Red No. 3 is not included in AB 2316 because it is already covered by AB 418.

Other State Action

The Red No. 3 ban exists within a wave of state-level food chemical legislation. As of early 2026, more than 15 state food chemical bills have been enacted, with nearly 70 introduced across state legislatures.

State	Legislation	Scope	Status
West Virginia	HB 2354	Bans Red No. 3 and 8 other dyes/additives in retail food (Jan 2028) and school meals (Aug 2025)	Enacted; retail provisions subject to preliminary injunction (Dec 2025)
Utah	HB 402	Bans Red No. 3 and 8 other dyes/additives in school food	Law effective May 7, 2025; school compliance 2026-27
Arizona	HB 2164	Bans Red No. 3 and other dyes in school food	Effective 2026-2027 school year
Virginia	S 1289/H 1910	Bans Red No. 3 and 6 other dyes in school food	Effective July 1, 2027
Illinois, New York, Pennsylvania	Various	Pending legislation to ban Red No. 3 in consumer food	Introduced 2025

Key Deadlines

Date	Event	Scope
January 15, 2025	FDA issues final order revoking Red No. 3 listings	90 FR 4628
February 18, 2025	Deadline for objections and hearing requests	FD&C Act Section 721(d)
April 22, 2025	FDA/HHS announce broader synthetic dye phase-out (MAHA initiative)	All 8 certified synthetic food dyes
January 1, 2027	California AB 418 takes effect	Food products sold in California
January 15, 2027	FDA food ban effective — 21 CFR 74.303 removed	All food products, dietary supplements
January 18, 2028	FDA drug ban effective — 21 CFR 74.1303 removed	All ingested drugs (Rx and OTC)

These are hard deadlines, not voluntary targets. After January 15, 2027, any food product containing FD&C Red No. 3 is deemed adulterated under the FD&C Act and subject to FDA enforcement action — including seizure, injunction, and import detention.

Detailed Analysis

The Delaney Clause: No Safe Dose for Carcinogens

The Delaney Clause was enacted as part of the 1960 Color Additives Amendment to the FD&C Act. Its language is absolute: if a color additive is "found to induce cancer when ingested by man or animal," the FDA may not list it for use. There is no threshold analysis, no risk-benefit weighing, and no human-relevance exception.

Two studies published in the 1980s established that FD&C Red No. 3 induces thyroid follicular cell adenomas and carcinomas in male rats when administered at high doses over their lifetimes. The mechanism is species-specific: erythrosine inhibits thyroid peroxidase in rats, disrupting thyroid hormone regulation in a way that promotes tumor growth. This mechanism has not been observed in female rats, mice, gerbils, dogs, or humans.

The FDA has long acknowledged this science. In 1990, the agency used the same evidence to terminate Red No. 3's provisional listing in cosmetics and external drugs. The question was never whether the Delaney Clause applied — it was whether the FDA would act on food and ingested drug listings that relied on the same clause.

The CSPI Petition: 35 Years in the Making

The path to the 2025 ban was decades long:

• 1990: The FDA bans Red No. 3 in cosmetics and external drugs, citing the Delaney Clause. The food and ingested drug listings survive — an inconsistency that CSPI and other advocates would challenge repeatedly.
• 2008: CSPI files a citizen petition (FDA-2008-P-0349) requesting the ban of all eight certified artificial food dyes, including Red No. 3, citing evidence of behavioral effects in children and the existing cancer finding. The FDA does not act on the petition.
• October 2022: CSPI, joined by 22 co-petitioners — including the American Academy of Pediatrics, Consumer Reports, and the Environmental Defense Fund — files a formal color additive petition specifically invoking the Delaney Clause. The petition argued that the FDA had no legal discretion to maintain the listing given its own 1990 cancer finding.
• January 2025: The FDA issues its final order, conceding the legal argument. The agency states: "Based on our review of the available relevant data and information, FDA has concluded that FD&C Red No. 3 has been found to induce cancer in laboratory animals and, therefore, may no longer be listed for use as a color additive in food or ingested drugs under the Delaney Clause."

The 35-year gap between the cosmetics ban and the food ban is widely regarded as one of the most conspicuous regulatory inconsistencies in FDA history. The same evidence base, the same statutory clause, applied to different product categories — with no scientific rationale for the divergence.

The MAHA Acceleration

Rather than opposing the Biden-era ban, the Trump administration embraced and expanded it. The April 22, 2025 announcement by HHS Secretary Kennedy and FDA Commissioner Makary positioned the Red No. 3 ban as the opening act of a broader regulatory transformation:

• Immediate revocation proceedings initiated for Citrus Red No. 2 and Orange B (both rarely used)
• Voluntary industry timeline to eliminate six remaining synthetic dyes (Red 40, Yellow 5, Yellow 6, Blue 1, Blue 2, Green 3) by end of 2026
• Accelerated natural colorant approvals — FDA authorized four new natural color additives and committed to fast-tracking additional applications
• Industry pledge tracking — FDA created a public dashboard to track corporate commitments to reformulate

The administration explicitly called on food companies to remove Red No. 3 ahead of the January 2027 deadline. While not legally binding, this request carries significant weight given the current regulatory and political environment.

International Context

Erythrosine (E127) remains permitted in several major markets, though often with restrictions:

• European Union: Approved for limited uses — primarily maraschino/cocktail cherries, candied cherries, and bigarreaux cherries. The EU's Scientific Committee on Food established an Acceptable Daily Intake (ADI) of 0.1 mg/kg body weight/day. The EU does not apply a Delaney-type absolute prohibition.
• Japan: Permitted as "Food Red No. 3" under Japan's list of designated additives, including the aluminum lake form.
• Canada: Erythrosine is listed as a permitted food color.
• Australia/New Zealand: Permitted under Food Standards Code as E127.

The U.S. ban is the most restrictive action any major regulatory body has taken against erythrosine. Companies selling internationally should note that the FDA action does not affect the legality of Red No. 3 in foreign markets — but global reformulation to a single natural-colorant specification may be more cost-effective than maintaining dual formulations.

Affected Product Categories

The ban affects any food product, dietary supplement, or ingested drug that lists FD&C Red No. 3, erythrosine, or E127 as an ingredient. The EWG estimated that approximately 3,000 food products in the U.S. market contained Red No. 3 at the time of the ban announcement.

Food Products

• Confections and frostings — Valentine's Day candy hearts (Brach's), cake decorations, icings, frostings, sprinkles
• Soft candy — Gummy candies, fruit chews, candy corn, PEZ fruit assortments
• Baked goods — Strawberry-flavored pastries, snack cakes (Hostess), cake mixes
• Fruit products — Maraschino cherries, canned fruit cocktail (cherry components), fruit-flavored snacks
• Nonalcoholic beverages — Strawberry-flavored drinks, nutrition shakes, flavored waters
• Cereals — Certain fruit-flavored cereals with red/pink coloring
• Dairy — Strawberry-flavored yogurt, flavored milk products
• Frozen desserts — Strawberry ice pops, flavored ice cream

Prescription and OTC Drugs

• Cherry-flavored and strawberry-flavored liquid medications
• Red-coated tablets (analgesics, antihistamines, allergy medications)
• Gummy vitamins and chewable supplements
• Oral suspensions with red/pink coloring

Drug products face the later January 18, 2028 deadline, reflecting longer reformulation timelines for stability testing, supplemental NDA/ANDA filings, and potential bioequivalence studies.

Dietary Supplements

Dietary supplements are classified as food under the FD&C Act and follow the January 15, 2027 food deadline. Multivitamins, gummy supplements, and chewable tablets frequently use Red No. 3 for coloring.

What Companies Should Do

Immediate Actions (Now Through Mid-2026)

1. Complete a full ingredient audit. Identify every SKU that lists FD&C Red No. 3, erythrosine, or E127. This includes contract-manufactured products, private-label lines, and products where you control the specification. Check color additive blends — some contain erythrosine as a component without listing it separately.

2. Map your compliance timeline. The binding deadlines are January 15, 2027 (food) and January 18, 2028 (drugs), but your effective deadline may be earlier:

   • If you sell in California: January 1, 2027 (AB 418)
   • If you supply school food channels: Check Utah (effective now), Arizona and Virginia deadlines
   • If you have MAHA-aligned corporate commitments: Your public pledge date

3. Source natural alternatives. The primary replacements for Red No. 3 are:

   • Beet juice concentrate — Good color match, pH-sensitive, requires reformulation testing
   • Red cabbage extract — Broad pH range, purple-to-red spectrum
   • Carmine (cochineal) — Excellent stability, requires allergen disclosure per 21 CFR 73.100
   • Purple sweet potato, radish, and fruit/vegetable juice blends — Variable stability

   Natural red colorants are experiencing supply pressure as demand surges industry-wide. Secure supply agreements early.

4. Begin stability testing. Color reformulation typically requires 6-12 months of stability data. Companies that have not started testing by mid-2026 are at serious risk of missing the January 2027 food deadline.

Reformulation Considerations

• Cost: Industry estimates for color reformulation range from $50,000 to $200,000 per SKU, including stability testing, packaging updates, and label reprinting. Companies with large portfolios face multi-million-dollar programs.
• Labeling: Updated ingredient lists must comply with 21 CFR 101.22. Switching from a certified color to an exempt color changes the declaration from "FD&C Red No. 3" to the common name of the natural source (e.g., "beet juice concentrate for color").
• Consumer messaging: The reformulation environment is favorable. Consumer sentiment driven by MAHA and state-level activism means that removing synthetic dyes is broadly perceived as a positive move. Several companies are using the transition as a marketing opportunity.

For Pharmaceutical Companies

Drug reformulation carries additional regulatory burden beyond the color change itself:

• Supplemental NDA/ANDA filings may be required for color changes to approved drugs
• Stability testing under ICH guidelines: typically 6 months accelerated and 12-24 months real-time
• Bioequivalence is generally not affected by inactive ingredient changes, but FDA guidance should be consulted for specific product types
• The January 18, 2028 deadline provides additional runway, but pharmaceutical development timelines mean companies should be actively working on reformulation now

Enforcement Outlook

Post-January 15, 2027, any food product containing FD&C Red No. 3 will be adulterated under Section 721 of the FD&C Act. The FDA can pursue warning letters, import alerts and detention without physical examination (DWPE), seizure of adulterated products, and injunctions against non-compliant manufacturers.

Given the MAHA initiative's political visibility and the FDA's public commitment to eliminating synthetic dyes, enforcement is expected to be aggressive. Companies that miss the deadline face regulatory action, reputational risk, and potential state-level civil penalties in California and other jurisdictions with independent enforcement mechanisms.

Major Industry Reformulation Commitments

Several major food manufacturers have publicly committed to reformulation timelines:

Company	Commitment
General Mills	Synthetic dyes out of cereals and school food by summer 2026; full U.S. portfolio by end of 2027. 85% of U.S. products already free of certified color additives.
Mars	States no U.S. candies currently use Red No. 3.
Conagra Brands	School foodservice products dye-free by 2026-27 academic year; full U.S. retail by end of 2027.
JM Smucker (Hostess)	Began reformulating snack cakes and fruit pies in January 2025; full brand portfolio by end of 2027.

Companies that have not announced reformulation plans should treat this as urgent. The January 2027 deadline is less than 10 months away, and the broader synthetic dye phase-out means that reformulation resources — including food scientists, natural colorant suppliers, and testing capacity — are in high demand across the industry.

The Bigger Picture

The Red No. 3 ban is not an isolated regulatory event. It is the opening move in what appears to be a comprehensive elimination of petroleum-based synthetic food dyes from the U.S. market. The FDA's April 2025 announcement targeting six additional dyes for voluntary phase-out by end of 2026 — followed by potential regulatory action — signals that companies relying on any synthetic colorant should be planning portfolio-wide reformulation.

Companies still working on Red No. 3 compliance should treat this as the first phase of a multi-year program that will eventually touch every synthetic dye in their formulations. Those that act early will have a competitive advantage in securing natural colorant supply, building reformulation expertise, and positioning their brands in an increasingly health-conscious market.